Spirulina extracellular vesicle carried astaxanthin hydrogel as well as preparation method and application thereof
By preparing Spirulina extracellular vesicles loaded with astaxanthin hydrogel, the water solubility and stability problems of astaxanthin in the treatment of radiation dermatitis were solved, achieving effective prevention and treatment of radiation dermatitis.
Patent Information
- Application Number
- CN202510830605.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-06-20
- Publication Date
- 2025-09-30
AI Technical Summary
The existing technology lacks effective targeted drugs to alleviate the oxidative stress of radiation dermatitis and maintain mitochondrial homeostasis, and the water solubility and stability of astaxanthin limit its application in the treatment of radiation dermatitis.
By preparing Spirulina extracellular vesicles loaded with astaxanthin hydrogel, using Spirulina extracellular vesicles to encapsulate astaxanthin, and incorporating it into aldehyded hyaluronic acid/carboxymethyl chitosan hydrogel, a skin radiation protection dressing is formed to promote the delivery of astaxanthin to the skin.
It improves the bioavailability of astaxanthin, simplifies the production process, reduces costs, and significantly alleviates the symptoms of radiation dermatitis by regulating skin mitochondrial homeostasis, repairing tissue lesions, and promoting skin regeneration.
Smart Images

Figure CN120713858A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of biomedicine, and in particular relates to a spirulina extracellular vesicle-loaded astaxanthin hydrogel, a preparation method and uses thereof. Background Art
[0002] Radiotherapy is one of the most important treatments for cancer. Although the therapeutic effects of radiotherapy have been proven, accidental exposure of healthy tissues to additional radiation doses remains an inevitable clinical challenge. Radiation dermatitis is one of the most common side effects of radiotherapy. In the early stages of radiation dermatitis, the skin presents with mild erythema, dryness, scaling, and itching. As time goes by and the cumulative dose increases, the skin becomes more severely damaged, evolving into moist scaling, exudation, and hemorrhagic crusting. In severe cases, this condition can progress to skin ulcers and necrosis. Given the potential damage mechanisms of radiation dermatitis, there is an urgent need for radioprotectants that can reduce oxidative stress and maintain mitochondrial homeostasis to inhibit the development of radiation dermatitis. However, to date, no targeted drug therapy has been successfully developed for clinical application.
[0003] Extracellular vesicles (EVs) are lipid bilayer nanovesicles released by various cell types, facilitating the transport of bioactive molecules between cells, tissues, individuals, and even species. Due to their diverse molecular composition, unique vesicle structure, nanoscale size, and excellent biocompatibility, EVs have attracted significant attention as therapeutic agents and drug delivery vehicles. Microalgae are photosynthetic organisms that can secrete EVs. Compared with EVs derived from animal cells, microalgae-derived EVs offer advantages such as greater availability, cost-effective large-scale production, and suitability for development as engineered nanoparticle drug delivery vehicles. Spirulina, an edible, naturally occurring microalgae rich in protein, essential amino acids, carbohydrates, lipids, vitamins, and minerals, is a highly valuable natural food source. In recent years, its rich bioactive compounds, such as carotenoids and phycocyanins, have attracted significant attention due to their potential antioxidant and anti-inflammatory properties and potential benefits for human health. Astaxanthin, a powerful antioxidant that effectively scavenges free radicals, is considered a promising natural radioprotectant. However, its poor water solubility and limited stability greatly restrict its bioavailability, posing challenges to its clinical application.
[0004] Building on this background, the present invention, for the first time, encapsulates astaxanthin in engineered Spirulina extracellular vesicles, promoting the synergistic and complementary effects of the two, increasing astaxanthin's bioavailability and leveraging their antioxidant and anti-inflammatory properties. To better meet the requirements of transdermal administration, the aforementioned materials are incorporated into a biocompatible aldehyde-modified hyaluronic acid / carboxymethyl chitosan hydrogel to create a skin radiation-protective dressing, potentially advancing targeted treatments for radiation dermatitis and personalized medicine. Summary of the Invention
[0005] The purpose of the present invention is to address the deficiencies in the existing technology and provide a natural, environmentally friendly, simple, feasible and scalable preparation method of Spirulina extracellular vesicle-loaded astaxanthin hydrogel and its application in radiation dermatitis.
[0006] The technical solution adopted by the present invention is as follows: as a first aspect, a method for preparing a Spirulina extracellular vesicle-loaded astaxanthin hydrogel is provided, comprising the following steps: loading astaxanthin into Spirulina extracellular vesicles by ultrasound and co-incubation to form Spirulina extracellular vesicle-loaded astaxanthin nanoparticles, wherein the mass ratio of astaxanthin to Spirulina extracellular vesicles is 1:7; adding the Spirulina extracellular vesicle-loaded astaxanthin nanoparticles to an aldehyded hyaluronic acid / carboxymethyl chitosan hydrogel, and mixing at room temperature (rapid gelation can be achieved in 55 seconds) to form the Spirulina extracellular vesicle-loaded astaxanthin hydrogel.
[0007] Furthermore, the Spirulina extracellular vesicles are prepared by the following steps:
[0008] Take the Spirulina liquid, centrifuge it at 5000×g and 4°C for 15 minutes, discard the precipitate, take the supernatant, centrifuge it at 11000×g and 4°C for 30 minutes, and discard the precipitate; continue to take the supernatant, filter it with a 0.22 μm filter membrane, ultracentrifuge the filtrate at 100000×g and 4°C for 1.5 hours, and discard the supernatant; take the precipitate, resuspend it with PBS, and ultracentrifuge it at 100000×g and 4°C for 1.5 hours to finally obtain the purified Spirulina extracellular vesicles, resuspend it with pre-chilled PBS, and store it at -80°C.
[0009] Furthermore, the method of loading astaxanthin into Spirulina extracellular vesicles by ultrasound and co-incubation to form Spirulina extracellular vesicle-loaded astaxanthin nanoparticles comprises:
[0010] The concentration of Spirulina extracellular vesicles was quantified using the BCA method (Bicinchoninic Acid Assay). Astaxanthin and Spirulina extracellular vesicles were weighed and mixed in PBS. The mass ratio of astaxanthin to Spirulina extracellular vesicles was 1:7.
[0011] The mixture was placed in an ice box (0–4°C), sonicated at a power of 150 W for 3 min (on / off for 15 s), and incubated on ice for 2 h;
[0012] Purification and enrichment were performed to obtain Spirulina extracellular vesicles loaded with astaxanthin nanoparticles, which were resuspended in pre-cooled PBS and stored at -80°C.
[0013] In some preferred embodiments, the purification comprises:
[0014] The mixture after co-incubation on ice was centrifuged at 2000×g and 4°C for 5 min, the precipitate was discarded, and the supernatant was taken. 10 times the volume of pre-cooled PBS was added to the supernatant, and the mixture was centrifuged at 5000×g and 4°C for 15 min to collect the supernatant.
[0015] In some preferred embodiments, the enrichment comprises:
[0016] The purified supernatant was ultracentrifuged at 100,000×g and 4° C. for 1.5 h to obtain the precipitate, which was the Spirulina extracellular vesicles-loaded astaxanthin nanoparticles.
[0017] Furthermore, the aldehyde-modified hyaluronic acid is prepared by the following method:
[0018] Dissolve 2 g of sodium hyaluronate in 100 mL of distilled water and stir thoroughly. Then, add 1.064 g of sodium periodate in a light-proof environment and react at room temperature for 24 h. Add 1.5 mL of ethylene glycol to terminate the reaction, dialyze, and freeze-dry to obtain aldehyde-modified hyaluronic acid.
[0019] Furthermore, the astaxanthin-loaded spirulina extracellular vesicle nanoparticles are added to the aldehyded hyaluronic acid / carboxymethyl chitosan hydrogel and mixed at room temperature, comprising:
[0020] Using PBS containing Spirulina extracellular vesicles-loaded astaxanthin nanoparticles as solvent, 5-6% of aldehyded hyaluronic acid and 5-6% of carboxymethyl chitosan were prepared in a mass ratio of 1:1 and mixed to prepare Spirulina extracellular vesicles-loaded astaxanthin hydrogel.
[0021] Preferably, the mass ratio of the prepared aldehyde-modified hyaluronic acid is 5% and the mass ratio of the prepared aldehyde-modified hyaluronic acid is 5%.
[0022] As a second aspect, provided is a Spirulina extracellular vesicle-loaded astaxanthin hydrogel prepared by the preparation method described in the first aspect.
[0023] As a third aspect, an application of the Spirulina extracellular vesicle-loaded astaxanthin hydrogel is provided for preparing a skin dressing for preventing skin mitochondrial homeostasis imbalance and / or tissue lesions and / or skin oxidative stress and / or skin inflammation caused by radiotherapy rays.
[0024] The beneficial effects of the present invention are:
[0025] (1) The present invention effectively improves the low bioavailability of astaxanthin by encapsulating astaxanthin with isolated Spirulina extracellular vesicles;
[0026] (2) The method is simple and feasible, the production cost is low, the components are highly safe, the administration method is highly operable, and it has great potential for clinical translation;
[0027] (3) External application of Spirulina extracellular vesicles loaded with astaxanthin hydrogel can prevent radiation dermatitis by regulating skin mitochondrial homeostasis, repairing skin tissue lesions, promoting normal epidermal proliferation, inhibiting abnormal collagen deposition, and anti-oxidation and anti-inflammatory. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] Figure 1 TEM images of Spirulina extracellular vesicles (SP-EVs) and Spirulina extracellular vesicles loaded with astaxanthin (SP-EVs@AST);
[0029] Figure 2 is the particle size of Spirulina extracellular vesicles (SP-EVs) and Spirulina extracellular vesicles loaded with astaxanthin (SP-EVs@AST);
[0030] Figure 3 is the zeta potential of hydrogel (Gel), Spirulina extracellular vesicles (SP-EVs), free astaxanthin (AST), and Spirulina extracellular vesicles loaded with astaxanthin (SP-EVs@AST);
[0031] Figure 4 are the UV spectrophotometric values of Spirulina extracellular vesicles (SP-EVs), Spirulina extracellular vesicles loaded with astaxanthin (SP-EVs@AST), and free astaxanthin (AST);
[0032] Figure 5 The solubility of astaxanthin-loaded extracellular vesicles of Spirulina at different ratios (SP-EVs@AST);
[0033] Figure 6 The figures show the properties of Spirulina extracellular vesicle-loaded astaxanthin hydrogels. Figure (a) shows the adhesion test of Spirulina extracellular vesicle-loaded astaxanthin hydrogels at different concentrations, Figure (b) shows the rheological test of 5% concentration hydrogels, Figure (c) shows the plasticity test of 5% concentration hydrogels, and Figure (d) shows the swelling test of 5% concentration hydrogels.
[0034] Figure 7 This is the change curve of the release of Spirulina extracellular vesicle-loaded astaxanthin nanoparticles from Spirulina extracellular vesicle-loaded astaxanthin hydrogel at 37 degrees Celsius and pH = 5 / 7 / 8;
[0035] Figure 8 In vitro uptake of astaxanthin-loaded Spirulina extracellular vesicle nanoparticles by immortalized human epidermal cells;
[0036] Figure 9Comparison of the effects of aldehyde-modified hyaluronic acid / carboxymethyl chitosan hydrogel Gel, Spirulina extracellular vesicle hydrogel SP-EVs gel, astaxanthin hydrogel AST gel, and Spirulina extracellular vesicle-loaded astaxanthin hydrogel SP-EVs@AST gel on X-ray-induced radiation-induced skin tissue lesions (skin epigenetic photographs, hematoxylin and eosin staining, Masson staining, and Picrosirius red staining); Figure (a) shows skin epigenetic photographs (left) and RTOG scores of mice in each group, and Figure (b) shows hematoxylin and eosin staining (HE), Masson staining (Masson staining), and Picrosirius red staining of skin tissue of mice in each group;
[0037] Figure 10 A comparison of the effects of aldehyde-modified hyaluronic acid / carboxymethyl chitosan hydrogel Gel, Spirulina extracellular vesicle hydrogel SP-EVs gel, astaxanthin hydrogel AST gel, and Spirulina extracellular vesicle-loaded astaxanthin hydrogel SP-EVs@AST gel on X-ray-induced skin blood flow reduction;
[0038] Figure 11 A comparison of the effects of aldehyde-modified hyaluronic acid / carboxymethyl chitosan hydrogel Gel, Spirulina extracellular vesicle hydrogel SP-EVs gel, astaxanthin hydrogel AST gel, and Spirulina extracellular vesicle-loaded astaxanthin hydrogel SP-EVs@AST gel on X-ray-induced skin mitochondrial damage;
[0039] Figure 12 Comparison of the effects of aldehyde-modified hyaluronic acid / carboxymethyl chitosan hydrogel Gel, Spirulina extracellular vesicle hydrogel SP-EVs gel, astaxanthin hydrogel AST gel, and Spirulina extracellular vesicle-loaded astaxanthin hydrogel SP-EVs@AST gel on X-ray-induced epidermal / epidermal stem cell apoptosis (Itgα6 and Ki67 immunofluorescence staining). Figure (a) shows Itgα6 and Ki67 immunofluorescence staining of mouse skin in each group, and Figure (b) shows the quantitative analysis of the above staining results (average OD value).
[0040] Figure 13 Comparison of the antioxidant effects of aldehyde-modified hyaluronic acid / carboxymethyl chitosan hydrogel Gel, Spirulina extracellular vesicle hydrogel SP-EVsgel, astaxanthin hydrogel AST gel, and Spirulina extracellular vesicle-loaded astaxanthin hydrogel SP-EVs@AST gel on X-ray-induced radiation skin damage model (SOD, GSH-Px activities and MDA content in skin tissue);
[0041] Figure 14Comparison of the anti-inflammatory effects of aldehyde-modified hyaluronic acid / carboxymethyl chitosan hydrogel Gel, Spirulina extracellular vesicle hydrogel SP-EVsgel, astaxanthin hydrogel AST gel, and Spirulina extracellular vesicle-loaded astaxanthin hydrogel SP-EVs@AST gel on the X-ray-induced radiation skin damage model (immunohistochemical staining of IL-6 and MPO in skin tissue; immunofluorescence staining of TGF-β). Figure (a) shows immunohistochemical staining of IL-6 and MPO and immunofluorescence staining of TGF-β in skin tissue of mice in each group, and Figure (b) shows the quantitative analysis of the above staining results (average OD value).
[0042] Figure 15 Pathological staining (hematoxylin and eosin staining, Masson staining, and picrosirius red staining) of mouse skin tissue after continuous administration of aldehyde-modified hyaluronic acid / carboxymethyl chitosan hydrogel Gel, Spirulina extracellular vesicle hydrogel SP-EVs gel, astaxanthin hydrogel AST gel, and Spirulina extracellular vesicle-loaded astaxanthin hydrogel SP-EVs@ASTgel for 28 days (once administered every 4 days);
[0043] Figure 16 Flow chart for the preparation of Spirulina extracellular vesicles loaded with astaxanthin hydrogel. Specific implementation methods
[0044] The present invention will be further described below with reference to the following drawings and examples, but the present invention is not limited to the following examples.
[0045] Example 1 Synthesis of Spirulina Extracellular Vesicles-Loaded Astaxanthin Nanoparticles
[0046] The process of preparing Spirulina extracellular vesicles loaded with astaxanthin hydrogel is as follows: Figure 16 As shown, including:
[0047] (1) Take Spirulina algae liquid, centrifuge at 5000×g and 4°C for 15 min, discard the precipitate, take the supernatant, centrifuge at 11000×g and 4°C for 30 min, and discard the precipitate; continue to take the supernatant, filter with a 0.22 μm filter membrane, ultracentrifuge the filtrate at 100000×g and 4°C for 1.5 h, and discard the supernatant; take the precipitate, resuspend it with PBS, and ultracentrifuge it at 100000×g and 4°C for 1.5 h to finally obtain purified Spirulina extracellular vesicles, resuspend it with pre-cooled PBS, and store at -80°C;
[0048] (2) The concentration of Spirulina extracellular vesicles was quantified by the BCA method. Astaxanthin and Spirulina extracellular vesicles were weighed and mixed in PBS. The mass ratio of astaxanthin to Spirulina extracellular vesicles was 1:3 to 1:11, and the final ratio was preferably 1:7.
[0049] (3) The mixture was placed in an ice box and sonicated at 150 W for 3 min (on / off for 15 s), and then incubated on ice for 2 h.
[0050] (4) The mixture was centrifuged at 2000 × g and 4°C for 5 min, the precipitate was discarded, and the supernatant was taken. The supernatant was added with 10 times the volume of pre-cooled PBS, and centrifuged at 5000 × g and 4°C for 15 min. The supernatant was collected and ultracentrifuged at 100000 × g and 4°C for 1.5 h to obtain the precipitate, which is the Spirulina extracellular vesicle-loaded astaxanthin nanoparticles. The precipitate was resuspended in pre-cooled PBS and stored at -80°C.
[0051] Its various characteristics such as Figure 1-5 As shown, the synthesized Spirulina extracellular vesicles-loaded astaxanthin nanoparticles have a vesicle structure, particle size and Zeta potential similar to those of Spirulina extracellular vesicles, and have the ultraviolet characteristic peaks of Spirulina extracellular vesicles and free astaxanthin, thereby improving the water solubility of free astaxanthin.
[0052] Example 2 Synthesis of Spirulina Extracellular Vesicles-Loaded Astaxanthin Hydrogel
[0053] (1) Dissolve 2 g of sodium hyaluronate in 100 mL of distilled water and stir thoroughly. Then, add 1.064 g of sodium periodate in a dark environment and react at room temperature for 24 h. Add 1.5 mL of ethylene glycol to terminate the reaction, dialyze, and freeze-dry to obtain aldehyde-modified hyaluronic acid.
[0054] (2) Using PBS containing Spirulina extracellular vesicles-loaded astaxanthin nanoparticles (200 μg / mL in this example) as a solvent, aldehyde-modified hyaluronic acid and carboxymethyl chitosan at a mass ratio of 2%, 3%, 4%, 5%, and 6% were prepared. The two components with the same mass ratio were mixed in a volume ratio of 1:1 to prepare Spirulina extracellular vesicles-loaded astaxanthin hydrogels with different concentrations.
[0055] like Figure 6 As shown, both the 5% and 6% groups formed adhesive hydrogels. The hydrogel synthesized with 5% aldehyde-modified hyaluronic acid and 5% carboxymethyl chitosan exhibited the best adhesion and was used in subsequent experiments. The Spirulina extracellular vesicle-loaded astaxanthin hydrogel produced with this ratio rapidly gelled within 55 seconds and exhibited excellent stretchability, plasticity, and stable swelling capacity.
[0056] Example 3 Drug Release Capacity
[0057] The in vitro drug release ability of Spirulina extracellular vesicles loaded astaxanthin hydrogel was tested using a cell chamber. The Spirulina extracellular vesicles loaded astaxanthin hydrogel sample was placed in a cell chamber, and physiological saline with pH = 5 / 7 / 8 was added to the lower layer, and the medium was released on a shaker at 37 degrees Celsius. 10 μL of release medium was taken out at different time points (1, 2, 4, 6, 8, 10, 12, 24, 36, 48h), and the same volume of fresh physiological saline was added. The protein concentration of the release medium collected at different time points was determined using BCA reagent. The results refer to Figure 7 The Spirulina extracellular vesicles-loaded astaxanthin hydrogel showed sustained release of Spirulina extracellular vesicles-loaded astaxanthin nanoparticles within 12 h.
[0058] Example 4 In vitro uptake of astaxanthin nanoparticles loaded in Spirulina extracellular vesicles
[0059] Spirulina extracellular vesicles loaded with astaxanthin nanoparticles were stained with PKH26 dye and ultracentrifuged at 100,000 x g and 4°C for 1.5 h to remove unbound dye. The stained nanoparticle pellet was resuspended in DMEM high glucose medium and added to human epidermal immortalized cells at different time points (1, 2, 4, 6, and 8 h) for co-incubation. The cell uptake in each group was observed under a confocal microscope. Figure 8 As shown, after 4 hours of co-incubation, it can be observed that the cells have obvious uptake of Spirulina extracellular vesicles loaded astaxanthin nanoparticles.
[0060] Example 5 Repairing the skin barrier
[0061] C57BL / 6J mice were divided into six groups: control, IR (irradiation), Gel, SP-EVs gel, AST gel, and SP-EVs@AST gel, with 10 mice in each group. Two days prior to irradiation, the dorsal area near the tail was shaved. The shaved area on the back measured 2 cm x 2 cm. One day prior to irradiation, mice were pretreated with gel, SP-EVs gel, AST gel, or SP-EVs@AST gel to acclimate. On the day of irradiation, the hydrogels were temporarily removed. All groups, except the control group, received 50 Gy of X-rays and then reapplied the corresponding hydrogels (using pentobarbital anesthesia during irradiation). Day 1 after irradiation was designated as day 1, and fresh hydrogels were applied to the irradiated skin area. Hydrogels were replaced and recorded on days 4, 8, and 12, with mice anesthetized with isoflurane before each procedure. Live imaging was performed on day 8, and mice were euthanized on day 16. The skin sections of the irradiated mice in each group were fixed and stained with HE, Masson and Picrosirius Red. Figure 9Treatment with SP-EVs@AST gel can effectively prevent X-ray damage to the skin and alleviate symptoms such as epidermal thickening and collagen disorder.
[0062] Example 6 Restoring subcutaneous blood flow
[0063] On the 8th day of the animal experiment mentioned in Example 5, in vivo laser speckle blood flow imaging was performed to evaluate the subcutaneous blood flow volume of mice. Figure 10 As shown, X-rays caused damage to skin vascular function, and the subcutaneous blood flow of mice returned to normal under the intervention of SP-EVs@AST gel.
[0064] Example 7 Restoring skin mitochondrial homeostasis
[0065] The irradiated skin of each group of mice in Example 5 was taken and the mitochondrial structure was observed under a transmission electron microscope. Figure 11 As shown in the results, X-rays induced mitochondrial swelling and cristae structure destruction, and SP-EVs@AST gel was able to restore the normal structure of mitochondria and maintain mitochondrial homeostasis.
[0066] Example 8: Promoting skin regeneration
[0067] The skin of each group of mice in Example 5 was fixed and sliced, and then immunofluorescence staining was performed to observe the expression of Itgα6 and Ki67 in skin cells in situ by immunofluorescence staining to show the proliferation of epidermal stem cells and epidermal cells. Figure 12 As shown, SP-EVs@AST gel can promote cell proliferation to promote skin regeneration.
[0068] Example 9: Anti-X-ray-induced oxidative stress
[0069] The skin of the irradiated part of each group of mice in Example 5 was ground and the supernatant was collected to detect the activities of SOD, GSH-Px and MDA to evaluate the antioxidant capacity. Figure 13 As shown in the results, the activities of antioxidant enzymes (SOD and GSH-Px) and the content of oxidative stress products (MDA) in the SP-EVs@AST gel group were higher, indicating that SP-EVs@AST gel can protect against X-ray-induced skin oxidative stress.
[0070] Example 10: Anti-X-ray-induced skin inflammation
[0071] The skin of the irradiated area of each group of mice in Example 5 was fixed and sectioned, and then immunohistochemical and immunofluorescent staining were performed to observe the distribution of IL-6, MPO, and TGF-β in the skin of each group in situ. Figure 14As shown in the data, the expression of pro-inflammatory factors IL-6 and MPO was reduced, and the expression of anti-inflammatory factor TGF-β was increased in the SP-EVs@AST gel group, indicating that SP-EVs@AST gel can alleviate X-ray-induced skin inflammation.
[0072] Example 11 Good in vivo safety
[0073] The gel, SP-EVs gel, AST gel or SP-EVs@AST gel were applied to the depilated back skin of mice every 4 days for 28 consecutive days, and the mouse skin was taken for pathological section staining. Figure 15 , HE, Masson, and Picrosirius Red jointly demonstrated that SP-EVs@AST gel had no adverse effects on the skin and had good safety.
[0074] In summary, the synthesized Spirulina EV-loaded astaxanthin hydrogel significantly improved the solubility and stability of astaxanthin while maintaining the structural integrity and bioactivity of Spirulina EVs, achieving a complementary and synergistic effect. By promoting skin regeneration, restoring mitochondrial function, alleviating oxidative stress, and reducing inflammatory responses, the hydrogel exhibited a preventive effect against radiation dermatitis, based on excellent biocompatibility.
Claims
1. A method for preparing a Spirulina extracellular vesicle-loaded astaxanthin hydrogel, characterized in that: The following steps are involved: Astaxanthin was loaded into Spirulina extracellular vesicles by ultrasound and co-incubation to form Spirulina extracellular vesicle-loaded astaxanthin nanoparticles, wherein the mass ratio of astaxanthin to Spirulina extracellular vesicles was 1:7; the Spirulina extracellular vesicle-loaded astaxanthin nanoparticles were added to the aldehyded hyaluronic acid / carboxymethyl chitosan hydrogel and mixed at room temperature to form the Spirulina extracellular vesicle-loaded astaxanthin hydrogel.
2. The preparation method according to claim 1, characterized in that The spirulina extracellular vesicles are prepared by the following steps: Take the Spirulina liquid, centrifuge it at 5000×g and 4°C for 15 minutes, discard the precipitate, take the supernatant, centrifuge it at 11000×g and 4°C for 30 minutes, and discard the precipitate; continue to take the supernatant, filter it with a 0.22 μm filter membrane, ultracentrifuge the filtrate at 100000×g and 4°C for 1.5 hours, and discard the supernatant; take the precipitate, resuspend it with PBS, and ultracentrifuge it at 100000×g and 4°C for 1.5 hours to finally obtain the purified Spirulina extracellular vesicles, resuspend it with pre-chilled PBS, and store it at -80°C.
3. The preparation method according to claim 1, characterized in that The method of loading astaxanthin into Spirulina extracellular vesicles by ultrasound and co-incubation to form Spirulina extracellular vesicle-loaded astaxanthin nanoparticles comprises: The concentration of Spirulina extracellular vesicles was quantified using the BCA method. Astaxanthin and Spirulina extracellular vesicles were weighed and mixed in PBS with a mass ratio of astaxanthin to Spirulina extracellular vesicles of 1:
7. The mixture was ultrasonically treated at a power of 150 W for 3 minutes at 0-4°C and incubated on ice for 2 hours. The mixture was purified and enriched to obtain Spirulina extracellular vesicle-loaded astaxanthin nanoparticles, which were resuspended in pre-chilled PBS and stored at -80°C.
4. The preparation method according to claim 3, characterized in that The ultrasonic treatment adopts an intermittent pulse mode, and the on-off state is cycled 6 times for 15 seconds each.
5. The preparation method according to claim 3, characterized in that The purification includes: centrifuging the mixture after co-incubation on ice at 2000×g and 4°C for 5 minutes, taking the supernatant, adding 10 times the volume of pre-cold PBS to the supernatant, centrifuging at 5000×g and 4°C for 15 minutes, and collecting the supernatant. The enrichment includes: ultracentrifuging the purified supernatant at 100,000×g and 4°C for 1.5 hours to obtain a precipitate, which is the Spirulina extracellular vesicle-loaded astaxanthin nanoparticles.
6. The preparation method according to claim 1, characterized in that The process of adding the astaxanthin-loaded spirulina extracellular vesicle nanoparticles to the aldehyde-modified hyaluronic acid / carboxymethyl chitosan hydrogel and mixing them at room temperature comprises: Using PBS containing Spirulina extracellular vesicles-loaded astaxanthin nanoparticles as a solvent, aldehyde-modified hyaluronic acid and carboxymethyl chitosan with a mass ratio of 5-6% and 5-6% respectively are prepared; the two are mixed at a volume ratio of 1:1 at room temperature to obtain Spirulina extracellular vesicles-loaded astaxanthin hydrogel.
7. The preparation method according to claim 6, characterized in that The mass ratio of aldehyde-modified hyaluronic acid to carboxymethyl chitosan is 5%.
8. The preparation method according to claim 6, characterized in that The aldehyde-modified hyaluronic acid was prepared by the following method: 2 g of sodium hyaluronate was dissolved in 100 mL of distilled water and stirred thoroughly; 1.064 g of sodium periodate was added in a light-proof environment, reacted at room temperature for 24 h, 1.5 mL of ethylene glycol was added to terminate the reaction, dialyzed, and freeze-dried to obtain the aldehyde-modified hyaluronic acid.
9. A Spirulina extracellular vesicle-loaded astaxanthin hydrogel prepared by the preparation method according to any one of claims 1 to 8.
10. A use of the Spirulina extracellular vesicle-loaded astaxanthin hydrogel according to claim 9, characterized in that: The spirulina extracellular vesicle-loaded astaxanthin hydrogel is used to prepare a skin dressing for preventing skin mitochondrial homeostasis imbalance and / or tissue lesions and / or skin oxidative stress and / or skin inflammation caused by radiotherapy rays.
Citation Information
Cited By
Cell membrane vesicle self-assembly body loaded with spirulina PDRN and preparation method of cell membrane vesicle self-assembly body
CN122075384A
